 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper   
127th MAINE LEGISLATURE  
 
FIRST REGULAR SESSION -2015  
 
Legislative Document  No. 812  
S.P. 286  In Senate, March 10, 2015  
 
 
An Act To Prevent Drug Overdose Deaths by Enhancing Access to 
Opioid Antagonists  
 
 
 
 
Reference to the Committee on Health and Human Services suggested and ordered printed.  
 
 
  
 HEATHER J.R. PRIEST  
 Secretary of the Senate  
 
Presented by Senator GRATWICK of Penobscot.  
Cosponsored by Representative GIDEON of Freeport and  
Senators: DIAMOND of Cumberland, DUTREMBLE of York, HILL of York, MIRAMANT 
of Knox, VALENTINO of York, Representatives: FREY of Bangor, LONGSTAFF of 
Waterville, PICCHIOTTI of Fairfield.  
 
 

 
 Page 1 - 127LR1047(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA ยง2353, as enacted by PL 2013, c. 579, ยง1, is repealed.  2 
Sec. 2.  22 MRSA ยง2353 -A is enacted to read:  3 
ยง2353 -A.  Opioid antagonists  4 
1.  Definitions.  As used in this section, unles s the context otherwise indicates, the 5 
following terms have the following meanings.  6 
A.  "Opioid antagonist" means a drug that binds to opioid receptors and blocks or 7 
inhibits the effects of opioids acting on those receptors, including, but not limited to, 8 
naloxone hydrochloride, naltrexone and other medicines of the same class as 9 
naloxone hydrochloride and naltrexone.  10 
B.  "Opioid -related drug overdose" means a condition including, but not limited to, 11 
extreme physical illness, decreased level of consciousnes s, respiratory depression, 12 
coma or death resulting from the consumption or use of an opioid, or another 13 
substance with which an opioid was combined, or a condition that a person would 14 
reasonably believe to be an opioid -related drug overdose that requires m edical 15 
assistance.  16 
2.  Immunity.  The following provisions govern immunity for persons who prescribe, 17 
possess or administer an opioid antagonist during an opioid -related drug overdose.  18 
A.  Notwithstanding any other provision of law, a health care practitio ner otherwise 19 
authorized to prescribe an opioid antagonist may, directly or by standing order, 20 
prescribe and dispense an opioid antagonist to a person at risk of experiencing an 21 
opioid -related drug overdose or to a family member or friend of such a person or 22 
another person in a position to assist a person at risk of experiencing an opioid - 23 
related drug overdose.  Any such prescription must be regarded as being issued for a 24 
legitimate medical purpose in the usual course of professional practice.  25 
B.  A health care practitioner who, acting in good faith and with reasonable care, 26 
prescribes or dispenses an opioid antagonist pursuant to paragraph A is not subject to 27 
criminal or civil liability or any professional disciplinary action for:  28 
(1)  Such prescribing or d ispensing; or  29 
(2) Any outcomes resulting from the administration of the opioid antagonist.  30 
C.  Notwithstanding any other provision of law, a person acting in good faith may 31 
possess an opioid antagonist.  32 
D.  A person who, acting in good faith and with reaso nable care, administers an 33 
opioid antagonist to another person whom the person believes to be experiencing an 34 
opioid -related drug overdose is immune from criminal prosecution, sanction under 35 
any professional licensing statute and civil liability for such a ct. 36 
3.  Exemption from pharmacy license for standing orders for opioid antagonists.  37 
Notwithstanding any other provision of law, a person acting under a standing order issued 38 
 
 Page 2 - 127LR1047(01) -1 
 by a health care practitioner who is otherwise authorized to prescribe an opioid antagonist 1 
may store and dispense an opioid antagonist without being subject to the provisions of 2 
Title 32, chapter 117 as long as these activities are undertaken without charge or 3 
compensation.  4 
4.  Drug therapy information sheet.  For each opioid antagoni st drug therapy 5 
initiated in accordance with this section, the licensed pharmacist dispensing the opioid 6 
antagonist shall provide the recipient of the opioid antagonist with a standardized fact 7 
sheet developed by the Maine Board of Pharmacy that includes, but is not limited to, the 8 
indications for use of the drug, the appropriate method for using the drug, the potential 9 
need for medical follow -up and referral information, information on opioid -related drug 10 
overdose and other appropriate information.  11 
5.  Confidentiality.   Nothing in this section affects the provisions of law relating to 12 
maintaining the confidentiality of medical records.  13 
SUMMARY  14 
This bill authorizes the prescription, possession and administration of opioid 15 
antagonists under certain circumstan ces and provides criminal and civil immunities for 16 
such prescription, possession and administration.  17 
 
